MRSA Clinical Trials 2024

MRSA Clinical Trials 2024

MRSA research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in methicillin-resistant staphylococcus aureus clinical trials today.

Popular filter options for mrsa trials

Mrsa Clinical Trials With No Placebo

View 9 mrsa medical studies that do not have a placebo group.

Brooklyn, New York

Behavioural Intervention

Hygiene protocol for Staph Infection

Recruiting5 awardsPhase 4
Brooklyn, New York

The overall goal of the project is to develop and evaluate a home-based intervention to prevent re-infection and transmission of Community-Acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) in patients presenting to primary care with skin or soft tissue infections (SSTIs). Centers for Disease Control (CDC) CA-MRSA guidelines include incision and drainage, antibiotic sensitivity testing and antibiogram-directed prescribing. Re-infections are common, ranging from 16% to 43%, and present significant challenges to clinicians, patients and their families. Several decolonization and decontamination interventions have been shown to reduce Hospital-Acquired MRSA (HA-MRSA) re-infection and transmission in intensive care units. Few studies examine the feasibility and effectiveness of these infection prevention interventions into primary care settings, and none employ Community Health Workers (CHWs) or "promotoras" to provide home visits for education and interventions about decolonization and decontamination. This comparative effectiveness research/patient centered outcomes research builds upon a highly stakeholder-engaged community-academic research and learning collaborative, including practicing clinicians, patients, clinical and laboratory researchers, and barbers/beauticians. Clinical Directors Network (CDN), an established, NIH-recognized best practice Federally Qualified Health Center (FQHC) Practice-based Research Network (PBRN), and The Rockefeller University propose to address this question through the completion of four aims: (1) To evaluate the comparative effectiveness of a CHW/Promotora-delivered home intervention (Experimental Group) as compared to Usual Care (Control Group) on the primary patient-centered and clinical outcome (SSTI recurrence rates) and secondary patient-centered and clinical outcomes (pain, depression, quality of life, care satisfaction) using a two-arm randomized controlled trial (RCT). (2) To understand the patient-level factors (CA-MRSA infection prevention knowledge, self-efficacy, decision-making autonomy, prevention behaviors/adherence) and environmental-level factors (household surface contamination, household member colonization, transmission to household members) that are associated with differences in SSTI recurrence rates. (3) To understand interactions of the intervention with bacterial genotypic and phenotypic variables on decontamination, decolonization, SSTI recurrence, and household transmission. (4) To explore the evolution of stakeholder engagement and interactions among patients and other community stakeholders with practicing community-based clinicians and academic laboratory and clinical investigators over the duration of the study period.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to mrsa

What are the top hospitals conducting mrsa research?

When it comes to tackling the challenging threat of Methicillin-resistant Staphylococcus aureus (MRSA), several hospitals are leading the charge in clinical trials. In Philadelphia, the Hospital of the University of Pennsylvania is at the forefront with one active MRSA trial. While they may not have conducted any previous trials for this specific condition, their expertise and dedication to research make them a trusted institution in fighting against MRSA. Similarly, Hamilton Health Sciences and St. Joseph's Healthcare Hamilton in Hamilton both have one ongoing MRSA trial each but haven't previously conducted any studies on this particular antibiotic-resistant bacteria. Kingston Health Sciences Centre in Kingston also joins this league with an active MRSA trial and no prior investigations recorded.

Moreover, stepping up to combat MRSA is the University of Arkansas for Medical Sciences located in Little Rock. With one current clinical trial focusing on this formidable bacterium, they too lack a history of past studies dedicated solely to MRSA.

These hospitals' commitment to undertaking current trials signifies their determination to find effective solutions against this persistent infection that continues to pose challenges within healthcare facilities worldwide. Though relatively fewer trials exist for MRSA when compared to other conditions, these institutions serve as beacons of hope for patients affected by antimicrobial resistance while demonstrating that every effort counts towards combating such resilient pathogens

Which are the best cities for mrsa clinical trials?

When it comes to MRSA clinical trials, several cities are at the forefront of research and innovation. Brooklyn, New york leads with 3 active trials investigating decolonization and decontamination methods among other treatments. Philadelphia, Pennsylvania follows closely with 2 ongoing studies focusing on VRE lipopeptide and chlorhexidine interventions. Hamilton, Ontario also hosts 2 active trials exploring vancomycin therapy alongside other approaches. Lastly, Baltimore, Maryland and Saint Louis, Missouri each have 2 active trials studying various treatment options including chlorhexidine. These cities provide valuable opportunities for individuals seeking participation in MRSA clinical trials to contribute to advancements in finding effective treatments for this challenging infection.

Which are the top treatments for mrsa being explored in clinical trials?

In the realm of MRSA treatment, one particular contender stands out in clinical trials. Vancomycin, a potent antibiotic introduced in 2004, is currently being explored in an active trial focused on combating MRSA. With six all-time trials dedicated to this challenging infection, vancomycin holds promise as a leading option for tackling MRSA and offering hope to patients affected by it.

What are the most recent clinical trials for mrsa?

Exciting advancements in the fight against MRSA are underway with recent clinical trials offering hope for improved treatment options. One such trial focuses on VRE lipopeptide, a potential breakthrough in combating MRSA infections. With Phase 2 results becoming available on September 1st, 2023, researchers are optimistic about its efficacy. Additionally, another study explores the use of chlorhexidine as a means to combat MRSA infections. Having reached Phase 4 and made available on May 1st, 2023, this trial provides valuable insights into the effectiveness of this approach. These pioneering investigations highlight the ongoing dedication to finding new strategies to tackle MRSA head-on and improve patient outcomes.

What mrsa clinical trials were recently completed?

Recently completed clinical trials focused on combating MRSA infections have made significant strides in the field of medical research. These trials bring hope for improved treatments against this challenging bacteria. Although specific details are limited, recent studies indicate that multiple clinical trials targeting MRSA were successfully concluded. The completion of these trials signifies progress in the development of novel therapies to combat MRSA and highlights ongoing efforts to address this pressing healthcare issue.